Multidrug-Resistant and Extremely Drug-Resistant Pseudomonas aeruginosa in Clinical Samples From a Tertiary Healthcare Facility in Nigeria
- 31 August 2022
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 19 (4), 447-454
- https://doi.org/10.4274/tjps.galenos.2021.66066
Abstract
Objectives: Pseudomonas aeruginosa has been globally implicated in healthcare-associated infection. The susceptibility pattern of clinical isolates of P. aeruginosa to anti-pseudomonal antibiotics is reported.Materials and Methods: Clinical samples, namely blood, urine, tracheal aspirate, cerebrospinal fluid (CSF), wound swabs, high vaginal swabs, eye, and ear exudates were obtained from patients, processed and identified using standard microbiological protocols. Antibiotic susceptibility testing was undertaken using the Kirby Bauer Disc diffusion method. Results were reported following the Clinical and Laboratory Standards Institute guidelines.Results: Of 104 P. aeruginosa isolates identified, males (52.88%) had a higher incidence of infection than female (47.11%) patients. The highest prevalence was recorded from wound swabs [46 (44.23%)] followed by ear exudates [23 (22.12%)], urine [22 (21.15%)], while eye exudates and samples from the CSF yielded the least [1 (0.96% each)]. From the antibiogram, imipenem had the highest antibiotic activity (91.3%) followed by polymyxin B (84.6%). The isolates exhibited the highest resistance to ceftazidime (73.1%) and piperacillin-tazobactam (61.5%). The antibiotic susceptibility pattern of P. aeruginosa isolates revealed 7.69% susceptible, 26% resistant, 61% multidrug resistance (MDR), 5% extremely drug resistance (XDR), and an absence (0%) of pandrug-resistant phenotypes.Conclusion: The study recorded alarmingly high cases of MDR and some XDR phenotypes of P. aeruginosa in University of Port Harcourt Teaching Hospital. It will help identify existing gaps in antimicrobial resistance surveillance and assist in improving public health policies regarding antibiotic stewardship, initiatives, and interventions.Keywords
This publication has 25 references indexed in Scilit:
- Pseudomonas aeruginosa ventilator-associated pneumonia managementInfection and Drug Resistance, 2016
- Carbapenem resistance inPseudomonas aeruginosaandAcinetobacter baumanniiin the nosocomial setting in Latin AmericaCritical Reviews in Microbiology, 2014
- Incidence of Multidrug Resistant Pseudomonas Aeruginosa Isolated from Burn Patients and Environment of Teaching InstitutionJournal of Clinical and Diagnostic Research, 2014
- A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011Pharmaceuticals, 2013
- Pseudomonas aeruginosa Biofilms in DiseaseMicrobial Ecology, 2013
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology & Infection, 2012
- Pseudomonas aeruginosa: all roads lead to resistanceTrends in Microbiology, 2011
- The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa InfectionsDrugs, 2007
- Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosaClinical Infectious Diseases, 2006
- National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002Antimicrobial Agents and Chemotherapy, 2004